SeqOnce

Accelerating next gen sequencing & diagnostics

Image-empty-state_edited.jpg
INVESTMENt

October, 2018

location

Los Angeles, CA, USA

Sector

Science

co-investors

MWV, Embark, InAmerica

Founder

Chris Angermayer, Co-Founder & CEO

SeqOnce is accelerating life science discoveries and improving patient outcomes by focusing on Next Gen Sequencing for genomics and diagnostics. SeqOnce’s proprietary technology uses a unique set of enzymatic reactions to reduce reaction steps and reagents. The result is a sample library prep kit that is fast, easy to use, and produces high-quality libraries regardless of sample source or application.